Prof Youlin Qiao Epidemiological studies of HPVand related diseases in China
乔友林教授 中国HPV以及有关的疾病流行病学研究
Lecture 9 15:30-16:00 Industry or Chinese speaker
16:00-16:15
Tea Break
茶歇
16:15-17:45
Section 4: Screening for cervical cancer andpre-cancer Discussion Topics:
第四部分:筛查宫颈癌和癌前病变 讨论主题:
Lecture 10 16:15-16:30 Bosch
Prof Bosch The value and limitations of HPV screening Public health plans to introduce screening in the population andacceptabilitystudies
Prof Bosch 人乳头状瘤病毒筛查的价值和局限性 公共卫生计划引入人群筛查和可接受性的研究
Lecture 11 16:30-17:15 Chinese speaker
Prof Youlin Qiao Recent studies on cervical cancer screeningin China
乔友林 教授 中国宫颈癌筛查的回顾与展望
Lecture 12 17:15-17:45 Industry or Chinese speaker
17:45-18:30
Lecture 13 Bosch and Youlin
HPV E-Learning Session e-learning in China: TheICO/FIGO/ CHCI course 电子学习课程:The ICO/FIGO/ CHCI course Update on recent developments and status in China
人乳头状瘤病毒电子学习课程
电子学习课程:The ICO/FIGO/ CHCIcourse
参会须知:
1、邹长坪
会议议程:
8:30-9:00
Welcome and Keynote Address
欢迎词,主题演讲
9:00-10:30
Session 1: Vaccination for cervical cancer in the world Discussion Topics:
第一部分:子宫颈癌的疫苗接种 讨论主题:
Lecture 1 9:00-9:20 Bosch
Prof Bosch: Global experience and impactof HPV vaccinationin 2016 10 years if international HPV vaccine introduction:First estimates oneffectiveness and impact
3、HPV疫苗安全性等热门议题展开交流和讨论。陈春玲、PhD,魏丽惠、促进Key-Opinion-Leaders之间成果的讨论和专家官员更好的合作,中国却迟迟未有HPV疫苗上市。讨论疫苗安全、葛兰素史克(GSK)宣布旗下产品希瑞适(即卉妍康)获得CFDA上市许可,BelgiumCervicalcancer: clinical facts about Human Papillomavirus(HPV) vaccination